520 Applewood Crescent
Vaughan, ON L4K 4B4
Industry: Medical Instruments & Supplies
Full-time employees: 12,900
|Mr. Osama A. Eldessouky||Exec. VP & CFO||1.09M||N/A||1972|
|Dr. Yehia Hashad M.D.||Exec. VP of R&D and Chief Medical officer||1.09M||N/A||1967|
|Mr. Brenton L. Saunders J.D.||CEO & Chairman||N/A||N/A||1970|
|Mr. Frederick J. Munsch||Sr. VP, Controller & Chief Accounting Officer||N/A||N/A||1971|
|Mr. A. Robert D. Bailey||Exec. VP & Chief Legal Officer||N/A||N/A||1963|
|Ms. Kelly Webber||Exec. VP & Chief HR Officer||N/A||N/A||N/A|
|Mr. Louis W. Yu||Exec. VP & Chief Quality Officer||N/A||N/A||1950|
|Mr. Dennis Asharin||Exec. VP and Chief Global Manufacturing & Supply Chain Officer||N/A||N/A||N/A|
|Luc Bonnefoy||Sr. VP of Surgical||N/A||N/A||N/A|
|Mr. John Ferris||Sr. VP of Consumer||N/A||N/A||N/A|
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.
Bausch + Lomb Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.